InvestorsHub Logo
Followers 3
Posts 231
Boards Moderated 0
Alias Born 07/28/2011

Re: Boing x 2 post# 13968

Tuesday, 06/23/2015 11:27:43 PM

Tuesday, June 23, 2015 11:27:43 PM

Post# of 20689
"Also, I believe we manufacturer the drug so we should realize the cost of the drug as income along with our 50/50 share after selling expenses if I am thinking right. "


No, I don't believe that is true. Like with Enoxoparin Sandoz will manufacture and distribute as well as set pricing. Sales will be reported by Novartis and profit is split after expenses determined by the original agreement "2006 Agreement" if I recall correctly, similar to Enox and then distributed to MNTA.